EU New Car Market 2026 Electric Vehicle Growth and Chinese Carmaker Expansion Highlighted by ACEA Data Amazon Appoints Telehealth Veteran to Lead Healthcare Unit Amid Expansion Efforts US Prioritizes AI Integration in Asia Following TrumpXi Meeting Taiwan Semiconductor Manufacturing Stock Approaches Milestone Amid AI Demand Surge US Consumer Pessimism Persists Economists Question When Sentiment Will Improve Djokovics Roland Garros Advance Endurance Under Extreme Heat May Signal Competitive Edge HuBS Q1 2026 Earnings EPS Beats Estimates by 809 as Stock Declines Certara Q1 2026 Earnings EPS Misses Estimates but Stock Gains 135 JJSF Q1 2026 Earnings EPS Misses Estimates Despite Narrow Surprise Stock Edges Higher QuinStreet QNST Q1 2026 Earnings EPS Misses Estimates Slightly Stock Gains on Operational Resilience SEE Q4 2025 Earnings EPS Beats Estimates by 428 as Operational Efficiency Drives Results Centrus Energy Corp Q1 2026 Earnings Stellar EPS Surprise Amid Nuclear Fuel Sector Momentum UMB Financial UMBF Slips 106 as Shares Test Key Support Levels SkyWest Inc SKYW Climbs 185 as Regional Aviation Demand Remains Robust TripAdvisor TRIP Edges Higher Navigating Support and Resistance at 1019 GXO Logistics GXO Holds Steady at 4774 Consolidation in a Tight Range Super League Enterprise Faces Bearish Pressure as Shares Decline 4 Rising Egg Prices Signal Broader Inflation Pressures on UK Household Essentials PPIH Q1 2026 Earnings Strong EPS Beat Drives Investor Attention Despite Mild Stock Decline Chubb Limited CB Holds Above Support After 148 Decline Insurance Sector Stays Defensive The9 Limited NCTY Holds Above Support After Marginal Decline Consolidation Continues Amerant Bancorp Inc AMTB Rallies 174 as Buyers Test Resistance Near 24 Aligos Therapeutics ALGS Posts Modest Gain Holds Near Support Zone Insperity Inc NSP Surges 4 as Shares Test Key Resistance Zone NeoGenomics Inc NEO Edges Higher as Stock Hovers Near Support in a Consolidative Phase Transdigm Group TDG Edges Higher as Aerospace Demand Supports Momentum Editas Medicine Gains 337 as Gene Editing Biotech Tests Key Resistance at 29